Key insights on how to approach Technology risks in Life Sciences and which are worth taking.
Aiming for a technological edge in today’s fast-paced marketplace may be one - or even the most - important factors to separate market participants from market leaders. But how can an organization get there without significantly increasing the (mostly unknown) risks that come with this new technological territory? A variety of promising emerging technologies (not yet fully adopted), such as Blockchain, Cloud-Computing, Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), or Low Code/No Code (LC/NC) are just some of the options organizations are taking a keen look towards.
In efforts to learn more about what is happening in the market, KPMG conducted a survey in the summer of 2022 with a focus on Healthcare and Life Science organizations. Throughout this blog, we dive into survey findings and more specifically, into of how these organizations are using technology and mitigating the risks involved with its use, including challenges and approaches that the industry should consider.